Deciphera Pharmaceuticals Announces $52 Million Series C Financing to Advance Novel Clinical-stage Oncology Pipeline Waltham, MA | June 1, 2017 Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug...
Harpoon Therapeutics Announces Completion Of $45M Series B Financing MPM Capital, Arix Bioscience, New Leaf Venture Partners and Taiho Ventures Participate in Immuno-Oncology Financing South San Francisco, CA—May 25, 2017-Harpoon Therapeutics, a biotechnology company...
Bioverativ to Acquire Clinical-Stage Rare Disease Biotechnology Company, True North Therapeutics – Strengthens pipeline with lead candidate TNT009 in cold agglutinin disease, a rare and chronic autoimmune hemolytic anemia with no approved therapies –...
Versartis Presents 3-Year Somavaratan Safety and Efficacy Data and Pediatric Program Baseline Demographics at the 19th European Congress of Endocrinology MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused...
Iterum Secures $65 Million in Series B Financing Funding to support the Phase 3 clinical development of oral penem antibiotic DUBLIN, IRELAND, and CHICAGO –May 19, 2017 – Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the...
Recent Comments